$QXO

QXO, Inc. (QXO) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 QXO Appoints Ken West as President and Chief Operating Officer GREENWICH, Conn. — August 24, 2026 — QXO, Inc. (NYSE: QXO), today announced the appointment of Ken West as President and Chief Operating Officer, effective September 1, 2026. West will report to Chief Exe

Investing.com reports QXO shares rose 2.7% in after-hours after the building products distributor posted Q2 results. Revenue was $3.25B versus $3.19B consensus, and adjusted EPS was $0.08, matching estimates. The report was its first since closing a $17B TopBuild acquisition, with results easing integration concerns.

QXO, Inc. (QXO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 QXO Reports Second Quarter 2026 Results GREENWICH, Conn. — August 13, 2026 — QXO, Inc. (“QXO” or the “Company”) (NYSE: QXO) today reported financial results for the second quarter of 2026. For the three months ended June 30, 2026, basic and diluted loss per common sh

QXO, Inc. (NYSE: QXO) shares fell about 23% in July, according to S&P Global Market Intelligence. The company did not report earnings but closed its $17 billion acquisition of TopBuild on July 1. The article links the decline to investor concerns about the deal and higher rates after oil prices rose amid tensions with Iran.

MarketBeat says Hims & Hers (HIMS) missed Q1 revenue and EPS estimates and faces higher customer acquisition costs. It also cites insider selling and notes deals including Novo Nordisk distribution and a $1.15B Eucalyptus acquisition. For QXO, it highlights a widening Q1 net loss and high short interest. For KLA (KLAC), it links the decline to semiconductor/AI sell-off and cyclical capex concerns.

A roundup of Tuesday Wall Street analyst actions included Deutsche Bank upgrading Palantir to Buy and keeping a $200 target, and Wells Fargo initiating APi Group at Overweight with a $53 target. Other calls covered CoreWeave, Micron, Walmart, Nike, Apple, and SK Hynix, with multiple price targets and rating changes ahead of earnings for some names.

Spyglass Capital Management’s Q2 2026 investor letter for its Spyglass Growth Strategy said the strategy gained 24.63% in Q2, citing easing geopolitical tensions and a software rebound. The letter highlighted QXO, Inc. (NYSE:QXO) as a new position after it announced a $17 billion acquisition of TopBuild, financed with QXO stock and debt. QXO closed at $13.46 on July 30, 2026.

KeyBanc kept an Overweight rating on QXO and cut its price target to $28 from $32 on July 1, citing lower market multiples after QXO shareholders approved its TopBuild acquisition. KeyBanc said deal arbitrage and a tough macro environment pressured shares, but deal closure and stability at Beacon are catalysts. QXO also said it closed the TopBuild deal and expects at least $300M annual synergies by 2030.

Mar Vista U.S. Quality Strategy’s Q2 2026 investor letter reported a +12.71% net return, below the Russell 1000 (+15.14%) and S&P 500 (+15.20%). It discussed QXO, Inc. (NYSE:QXO), noting shares closed at $14.58 on July 9, 2026, and underperformed amid housing weakness and high rates. The letter cites QXO’s acquisition of TopBuild as strengthening long-term positioning.

QXO shares rose about 8% after QXO said preliminary TopBuild (BLD) merger election results were released. About 91% of TopBuild shares elected cash consideration. Under proration, each TopBuild share will receive ~$249.71 cash plus 10.211 QXO shares (final agent calculations). Election ended June 29; closing expected around July 1, 2026.